Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Wee1 is a conserved Cdk1 inhibitory kinase operating at the G2/M checkpoint to prevent entry into mitosis until the genome has been surveilled and replication is complete. We report here that the early arrest mutant speedbump is a loss-of-function mutation in the zebrafish ortholog of wee1. Like other creatures lacking Wee1 kinase, cells in the mutant enter mitosis early. Eventually, mutant cells exhibit chromosomal defects and undergo apoptosis. Live recordings of the mutant reveal that as gastrula cells transition from maternal to zygotic control, their cell cycle gets progressively shorter rather than lengthening as seen in wild-type embryos. This suggests that Wee1 kinase inhibition is part of a mechanism to slow the cell cycle that we posit is independent of its role in blocking entry into mitosis to prevent DNA damage. Supporting this view, we show that Wee1 kinase is also crucial for tissues that normally exit the cell cycle in the G2 phase. In the absence of Wee1 kinase, hatching gland cells, which typically cease dividing before speedbump defects appear, no longer remain in G2, and instead advance into mitosis before prematurely dying. Finally, we demonstrate that Wee1 kinase is essential for the endoreplication cycle in the yolk cell. We show that wild-type yolk cell nuclei transition to an S and G endocycle after they cease mitosis in the blastula. However, without Wee1 kinase these nuclei have difficulty attaining this endocycle and sometimes regress back into mitosis. We conclude that besides the regulation of mitotic timing, Wee1 kinase has other G2 regulatory roles not previously reported in which controlling entry into mitosis must be coordinated with other cellular processes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ydbio.2025.08.006DOI Listing

Publication Analysis

Top Keywords

wee1 kinase
32
entry mitosis
12
cell cycle
12
wee1
10
kinase
9
yolk cell
8
mitosis
7
cell
5
regulatory processes
4
processes require
4

Similar Publications

Background: Chronic myeloid leukemia (CML) is a clonal malignancy propelled by the fusion gene originating from the Philadelphia chromosome. This gene activates ABL tyrosine kinase, which enhances the survival of leukemic cells. Although tyrosine kinase inhibitors (TKIs) have significantly advanced the treatment of CML, resistance to these inhibitors presents a substantial hurdle.

View Article and Find Full Text PDF

Genome-Wide Identification and Evolution of Core Cell Cycle Genes in Marchantia polymorpha: Insights Into Redundancy, Stress, and Functional Evolution.

Physiol Plant

August 2025

Fujian Provincial Key Laboratory of Haixia Applied Plant Systems Biology, State Key Laboratory of Ecological Pest Control for Fujian and Taiwan Crops, College of Life Sciences, College of Plant Protection, School of Future Technology, Haixia Institute of Science and Technology, Fujian Agriculture an

The cell cycle is a fundamental process of plant growth, development, and reproduction, in which cyclin-dependent kinases (CDKs) and cyclins (CYCs) play central roles in regulating the progression through various stages. These proteins are coordinated with multiple interacting partners to ensure the accurate execution of essential biological events such as DNA replication, chromosome segregation, and cell division. Marchantia polymorpha, one of the earliest diverging land plant species, has emerged as a key model for exploring fundamental mechanisms in plant biology and evolution.

View Article and Find Full Text PDF

The clinical effect of KRAS G12C inhibitors (G12Ci) as monotherapy is poor, prompting the development of combination treatment strategies. Here, we demonstrate that the WEE1 kinase inhibitor (WEE1i), Adavosertib, can sensitize the effect of G12Ci through the MYBL2-RRM2 axis, which is associated with poor prognosis in lung cancer. Overexpressing the MYBL2-RRM2 axis or supplementing the products of the RRM2 enzyme, dNTPs/dNs, can partially reverse this synergistic inhibitory effect.

View Article and Find Full Text PDF

Optimizing both on-target and off-target potencies is essential for developing effective and selective small-molecule therapeutics. Free energy calculations offer rapid potency predictions, usually within hours and with experimental accuracy and thus enables efficient identification of promising compounds for synthesis, accelerating early-stage drug discovery campaigns. While free energy predictions are routinely applied to individual proteins, here, we present a free energy framework for efficiently achieving kinome-wide selectivity that led to the discovery of selective Wee1 kinase inhibitors.

View Article and Find Full Text PDF

Colorectal cancer (CRC) is a heterogenous disease with distinct biological and clinical subgroups, each with different prognoses and responses to therapy. In this case report, taking inspiration from a case of locally advanced CRC with serine/threonine-protein kinase B-raf (BRAF) V600E mutation, we highlight an atypical consensus molecular subtype 1 (CMS1). Deep multi-omic analyses showed a limited expression of programmed cell death protein 1 (PD-1) and reduced T-cell infiltration, including CD8 and natural killer (NK) cells, in the analyzed CMS1 tumor.

View Article and Find Full Text PDF